PFS
JAZZ icon

Penseco Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Penseco Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3K Buy
+36
New +$2.9K ﹤0.01% 296

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Penseco Financial Services's JAZZ Position: Q3 2013 in Review

Penseco Financial Services opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2013: 36 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #296 among its holdings.

249 funds tracked by Wall St. Rank hold JAZZ as of Q3 2013.

  • Penseco Financial Services held 36 shares of Jazz Pharmaceuticals worth $3K as of Q3 2013.
  • Jazz Pharmaceuticals was a new Penseco Financial Services position in Q3 2013.
  • Jazz Pharmaceuticals made up ﹤0.01% of Penseco Financial Services's portfolio in Q3 2013, its #296 holding.
  • 249 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2013.

Based on Penseco Financial Services's 13F filing for Q3 2013, filed 4 Oct 2013.